Indonesia, the world's fourth most populous country, reported zero active clinical trials (250 units) in 2026, ranking 16 out of 197. This is not due to a lack of need — on the contrary, its vast population with diverse genetic and epidemiological profiles could be an ideal research setting. However, a weak regulatory framework, a shortage of skilled professionals, and limited funding have held the sector back. In recent years, Indonesia has begun attracting international pharmaceutical companies by streamlining approval processes.
Indonesia world ranking
Country position on the scale from last to first place for this indicator.
Change over time
Change in indicator over the available period.
Values — units
Top countries by Active clinical trials
Where Indonesia stands in the world ranking.
People also search for
Other pages of the reference by this indicator.